Neurocrine Bio. (NBIX) PT Raised to $170 at Oppenheimer
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.40 --0%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $170.00 (from $165.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $180 at Bernstein SocGen Group
- Aris Mining Corp (ARIS:CN) PT Raised to Cdn$46 at BMO Capital
- ZoomInfo Technologies (GTM) PT Lowered to $4.25 at DA Davidson to Reflect Sector Headwinds
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
